Or they've simply got a big few months coming up and are trying to tell a better story - what's the alternate, BOT should wallow in the acne results and try and tell a worse story?
It's not like the presentation leaves out the fact that they didn't meet the primary endpoint of the acne trial - they haven't at any stage run away from that.
It would be great to see a video of the presentation - PowerPoint slides without the narrative context are always a bit half-baked.
Ann: Cowen Conference and Additional BTX 1503 Data Analysis, page-29
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $1.091M | 2.847M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 372221 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 929664 | 19 |
View Market Depth
| Last trade - 12.48pm 01/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |